145 related articles for article (PubMed ID: 25411791)
41. Adult-onset mesangiocapillary glomerulonephritis: a disease with a poor prognosis.
Chan MK; Chan KW; Chan PC; Fang GX; Cheng IK
Q J Med; 1989 Jul; 72(267):599-607. PubMed ID: 2608879
[TBL] [Abstract][Full Text] [Related]
42. Outcome of idiopathic membranous nephropathy using targeted stepwise immunosuppressive treatment strategy.
Aaltonen S; Honkanen E
Nephrol Dial Transplant; 2011 Sep; 26(9):2871-7. PubMed ID: 21427071
[TBL] [Abstract][Full Text] [Related]
43. Prediction in idiopathic membranous nephropathy.
Marx BE; Marx M
Kidney Int; 1999 Aug; 56(2):666-73. PubMed ID: 10432407
[TBL] [Abstract][Full Text] [Related]
44. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).
Smith ER; Lee D; Cai MM; Tomlinson LA; Ford ML; McMahon LP; Holt SG
Nephrol Dial Transplant; 2013 Jun; 28(6):1569-79. PubMed ID: 23328709
[TBL] [Abstract][Full Text] [Related]
45. Posttransplantation glomerulonephritis: risk factors associated with kidney allograft loss.
Ostrowska J; Pazik J; Lewandowski Z; Mróz A; Perkowska-Ptasińska A; Durlik M
Transplant Proc; 2007 Nov; 39(9):2751-3. PubMed ID: 18021977
[TBL] [Abstract][Full Text] [Related]
46. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J
Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
[TBL] [Abstract][Full Text] [Related]
47. Hypertension, end-stage renal disease and mesangiocapillary glomerulonephritis in methamphetamine users.
Jones ES; Rayner BL
S Afr Med J; 2015 Mar; 105(3):199-201. PubMed ID: 26294827
[TBL] [Abstract][Full Text] [Related]
48. Pattern of renal diseases among adults in Saudi Arabia: a clinicopathologic study.
Al-Homrany MA
Ethn Dis; 1999; 9(3):463-7. PubMed ID: 10600069
[TBL] [Abstract][Full Text] [Related]
49. Low glomerular density is a risk factor for progression in idiopathic membranous nephropathy.
Tsuboi N; Kawamura T; Miyazaki Y; Utsunomiya Y; Hosoya T
Nephrol Dial Transplant; 2011 Nov; 26(11):3555-60. PubMed ID: 21771759
[TBL] [Abstract][Full Text] [Related]
50. Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease.
Perkins RM; Kirchner HL; Hartle JE; Bucaloiu ID
Clin Nephrol; 2013 Oct; 80(4):256-62. PubMed ID: 23993165
[TBL] [Abstract][Full Text] [Related]
51. Influence of tonsillectomy on the progression of mesangioproliferative glomerulonephritis.
Piccoli A; Codognotto M; Tabbi MG; Favaro E; Rossi B
Nephrol Dial Transplant; 2010 Aug; 25(8):2583-9. PubMed ID: 20200005
[TBL] [Abstract][Full Text] [Related]
52. Predictors of end-stage renal disease and recurrence of lupus activity after initiation of dialysis in patients with lupus nephritis.
Moon SJ; Park HS; Kwok SK; Ju JH; Kim HY; Park SH
Clin Exp Rheumatol; 2013; 31(1):31-9. PubMed ID: 22935632
[TBL] [Abstract][Full Text] [Related]
53. Membranoproliferative glomerulonephritis: the Cincinnati experience--cumulative renal survival from 1957 to 1989.
McEnery PT
J Pediatr; 1990 May; 116(5):S109-14. PubMed ID: 2329412
[TBL] [Abstract][Full Text] [Related]
54. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
Shen K; Yu Y; Tang Z; Liu Z; Li L
Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
[TBL] [Abstract][Full Text] [Related]
55. Advanced chronic kidney disease, end-stage renal disease and renal death among HIV-positive individuals in Europe.
Ryom L; Kirk O; Lundgren JD; Reiss P; Pedersen C; De Wit S; Buzunova S; Gasiorowski J; Gatell JM; Mocroft A;
HIV Med; 2013 Sep; 14(8):503-8. PubMed ID: 23590641
[TBL] [Abstract][Full Text] [Related]
56. Fibrillary and immunotactoid glomerulonephritis: Distinct entities with different clinical and pathologic features.
Rosenstock JL; Markowitz GS; Valeri AM; Sacchi G; Appel GB; D'Agati VD
Kidney Int; 2003 Apr; 63(4):1450-61. PubMed ID: 12631361
[TBL] [Abstract][Full Text] [Related]
57. Remission of proteinuria indicates good prognosis in patients with diffuse proliferative lupus nephritis.
Koo HS; Kim S; Chin HJ
Lupus; 2016 Jan; 25(1):3-11. PubMed ID: 26159540
[TBL] [Abstract][Full Text] [Related]
58. Long-term clinical and morphological evaluation of primary membranoproliferative glomerulonephritis.
Wu MJ; Shu KH; Chan LP; Lu YS; Cheng CH; Sheu SS; Hsu YH; Lian JD
Zhonghua Yi Xue Za Zhi (Taipei); 1996 Jan; 57(1):34-41. PubMed ID: 8820034
[TBL] [Abstract][Full Text] [Related]
59. Renal outcomes with aliskiren in patients with type 2 diabetes: a prespecified secondary analysis of the ALTITUDE randomised controlled trial.
Heerspink HJ; Persson F; Brenner BM; Chaturvedi N; Brunel P; McMurray JJ; Desai AS; Solomon SD; Pfeffer MA; Parving HH; de Zeeuw D
Lancet Diabetes Endocrinol; 2016 Apr; 4(4):309-17. PubMed ID: 26774608
[TBL] [Abstract][Full Text] [Related]
60. Outcomes and risk factors in patients with crescentic glomerulonephritis: a multicenter cohort study.
Su X; Song R; Li S; Guo W; Guo X; Qiao X; Wang L
J Nephrol; 2023 May; 36(4):1027-1035. PubMed ID: 36786975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
